BlackRock 2037 Municipal Target Term Trust (New York Stock Exchange:BMN)
| Market Cap | $134.45M-11.5% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 6.15M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Dec 11, 2026 |
| Volume | 50,705 |
| Open | $21.97 |
| Previous Close | $22.00 |
| Day's Range | $21.85 - $21.97 |
| 52-Week Range | $21.28 - $27.96 |
| Beta | 0.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About BMN
Launched by BlackRock, Inc., the BlackRock 2037 Municipal Target Term Trust operates as a closed-end mutual fund specializing in fixed-income investments. Its operations are overseen by BlackRock Advisors, LLC. The fund primarily allocates its capital to investment-grade municipal securities, requiring a minimum rating of BBB- from S&P and Fitch, or Baa3 from Moody's. This trust is officially domiciled in the United States.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Dec 11, 2026Ex-dividend date
$BMN stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of BMN by members of U.S. Congress
| Thomas Richard CarperSenate | Purchase$1.00K – $15.00K | Oct 27, 2022 |
Recently reported changes in BMN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BMN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BMN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BMN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BMN from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from BMN’s recent data — informational, not investment advice
